Elliott Associate Professor of Biology Kristian M. Hargadon ’01 recently joined the advisory board for Clinical and Translational Discovery, a new journal published by Wiley that aims to be at the forefront of research efforts to drive the future of molecular and precision-based medicine. Among the 53 advisory board members for the journal, Hargadon is the only professor from an undergraduate liberal arts institution and joins an international team of leading clinicians and clinical research scientists.
Hargadon's editorial highlights important links between COVID-19 and cancer as diseases of global health significance—it joins the editor-in-chief's as the opening articles for the inaugural issue.
Drawing attention to the significant advances in cancer research over the last decade made possible by The Cancer Genome Atlas (TCGA)—a comprehensive initiative that molecularly characterized more than 20,000 tumor and matched normal tissue samples across 33 distinct cancer types—Dr. Hargadon’s editorial highlights the need for a similar approach to address important questions related to COVID-19 disease progression. His article calls for a collaborative development of The COVID-19 Genome Atlas (TCGA2.0) to shape our understanding of and response to this pandemic disease.